Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$12.64 - $14.99 $7.77 Million - $9.22 Million
-615,000 Reduced 37.16%
1,040,000 $15.4 Million
Q2 2023

Aug 09, 2023

SELL
$9.85 - $13.17 $3.45 Million - $4.61 Million
-350,000 Reduced 17.46%
1,655,000 $21.4 Million
Q3 2022

Nov 09, 2022

SELL
$9.93 - $17.44 $3.13 Million - $5.49 Million
-315,000 Reduced 13.58%
2,005,000 $20.9 Million
Q2 2022

Aug 12, 2022

SELL
$7.45 - $12.83 $931,250 - $1.6 Million
-125,000 Reduced 5.11%
2,320,000 $29.2 Million
Q1 2022

May 10, 2022

BUY
$9.75 - $14.44 $19.3 Million - $28.6 Million
1,983,700 Added 430.02%
2,445,000 $26.5 Million
Q4 2021

Feb 10, 2022

SELL
$13.17 - $20.94 $3.67 Million - $5.84 Million
-278,700 Reduced 37.66%
461,300 $6.49 Million
Q3 2021

Nov 12, 2021

SELL
$9.16 - $19.83 $1.1 Million - $2.38 Million
-120,000 Reduced 13.95%
740,000 $14.2 Million
Q2 2021

Aug 11, 2021

SELL
$7.25 - $10.99 $797,500 - $1.21 Million
-110,000 Reduced 11.34%
860,000 $8.47 Million
Q1 2021

May 17, 2021

SELL
$4.57 - $11.18 $2.29 Million - $5.59 Million
-500,000 Reduced 34.01%
970,000 $9.54 Million
Q4 2020

Feb 12, 2021

BUY
$3.73 - $5.6 $746,000 - $1.12 Million
200,000 Added 15.75%
1,470,000 $6.54 Million
Q3 2020

Nov 12, 2020

SELL
$4.32 - $11.7 $216,000 - $585,000
-50,000 Reduced 3.79%
1,270,000 $5.49 Million
Q2 2020

Aug 07, 2020

BUY
$2.94 - $9.1 $380,142 - $1.18 Million
129,300 Added 10.86%
1,320,000 $11.7 Million
Q1 2020

May 15, 2020

BUY
$2.27 - $6.2 $499,400 - $1.36 Million
220,000 Added 22.66%
1,190,700 $4.2 Million
Q4 2019

Feb 14, 2020

BUY
$3.46 - $6.93 $311,400 - $623,700
90,000 Added 10.22%
970,700 $5.55 Million
Q3 2019

Nov 14, 2019

BUY
$2.69 - $4.85 $403,500 - $727,500
150,000 Added 20.53%
880,700 $3.15 Million
Q2 2019

Aug 14, 2019

BUY
$3.65 - $7.89 $511,000 - $1.1 Million
140,000 Added 23.7%
730,700 $2.92 Million
Q1 2019

May 13, 2019

BUY
$7.08 - $12.09 $516,132 - $881,361
72,900 Added 14.08%
590,700 $4.32 Million
Q4 2018

Feb 14, 2019

BUY
$8.14 - $13.28 $1.42 Million - $2.32 Million
175,000 Added 51.05%
517,800 $4.74 Million
Q3 2018

Nov 14, 2018

BUY
$11.85 - $16.0 $2.76 Million - $3.72 Million
232,800 Added 211.64%
342,800 $4.25 Million
Q2 2018

Aug 14, 2018

BUY
$15.15 - $20.75 $1.67 Million - $2.28 Million
110,000 New
110,000 $1.68 Million

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.63B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Edmond De Rothschild Holding S.A. Portfolio

Follow Edmond De Rothschild Holding S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Edmond De Rothschild Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Edmond De Rothschild Holding S.A. with notifications on news.